American Conference Institute (ACI) will be holding is 11th Annual Summit on Biosimilars: Legal, Regulatory, and Commercial Strategies for the Innovator and Biosimilars Marketplace on September 23-24, 2020 as a VIRTUAL conference. ACI faculty will offer presentations on the following topics:
• Regulatory and Legislative Developments Impacting the Pharmaceutical Industry
• Gauging the Impact of COVID-19 on the Global IP Marketplace
• Federal Circuit, PTAB, and District Court Decisions and their Impact on the Biosimilars Landscape
• Patent Eligibility and Biosimilar Patents
• Biosimilar Economics: Market Access, Sustainable Pricing, and Reimbursement
• The Pre-Suit BPCIA Tango: Production, Timing, and Notice of Commercial Marketing
• Antitrust Regulatory Enforcement, Litigation, Settlements, and Economic Considerations
• Comparison of Biosimilars Litigation in U.S. and Europe
• Biologic Drugs Scheduled to Lose Patent Protection and "Forward-Thinking" Portfolio Strategies
• Ethical Developments in Biologics and Biosimilars
Keynote talks include FDA's insights on implementing interchangeability for biosimilar products and FTC perspectives on antitrust considerations involving innovator biologic companies and biosimilar competitors. There will also be a panel of Administrative Patent Judges from the PTAB on practice before the Board, policies and procedures. And there will be a "town hall" discussion amongst in-house counsel regarding their expectations of their outside counsel counterparts.
An agenda for the conference and additional information regarding the workshops can be found here. A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
The early-bird registration fee if paid by September 4, 2020 is $1,595, and registration by September 22, 2020 is $1,795. Patent Docs readers are entitled to a 10% discount off of registration using discount code D10-658-658DX09. Those interested in registering for the conference can do so here, by e-mailing [email protected], or by calling 1-888-224-2480.
Patent Docs is a media partner of ACI's 11th Annual Summit on Biosimilars.
Comments